# Tomáš Boráň

Source: https://onco.cc/people/tomas-boran/  
OnCo record `tomas-boran` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

He has led SÚKL, Czechia's medicines regulator, since May 2024. SÚKL decides the price ceiling of a medicine and whether public health insurance pays for it.

## Summary

MUDr. Tomáš Boráň is director of the Státní ústav pro kontrolu léčiv (SÚKL), according to the list of directors on SÚKL's mandatory disclosure page, which gives his term as starting on 2 May 2024. He followed PharmDr. Jakub Velík, Ph.D., who had been entrusted with running the institute in the interim from 21 December 2023 to 30 April 2024. SÚKL, under the Ministry of Health, oversees medicines and authorises clinical trials in Czechia and, under Act 48/1997 Coll., sets maximum prices and the level and conditions of reimbursement of medicines, including temporary reimbursement of highly innovative cancer medicines.

## Fields

- Kind: Person
- Last checked: 2026-11-11
- Role: Director, State Institute for Drug Control (SÚKL), Prague
- Specialisms: Medicines regulation; Pricing and reimbursement of medicines

## Sources

- SÚKL: povinně zveřejňované informace (list of directors): https://sukl.gov.cz/o-nas/povinne-zverejnovane-informace/

## Connected records

- institutions: [State Institute for Drug Control (Státní ústav pro kontrolu léčiv, SÚKL)](https://onco.cc/institutions/sukl/)

---
JSON: https://onco.cc/api/v1/entities/tomas-boran.json